243695 ⎘
Nanotechnology; Specified use of nanostructure for medical, immunological, body treatment, or diagnosis; Drug delivery Liposome
MESOPOROUS SILICA NANOPARTICLES WITH LIPID BILAYER COATING FOR CARGO DELIVERY
#2TRANS-TYMPANIC MEMBRANE DELIVERY PLATFORM AND USES THEREOF
#3Stabilizing Camptothecin Pharmaceutical Compositions
#4LIPOSOME LOADING
#5Stabilizing Camptothecin Pharmaceutical Compositions
#6Liposomes Useful for Drug Delivery
#7Stabilizing Camptothecin Pharmaceutical Compositions
#8TUNEABLE DELIVERY OF NANOPARTICLE BOUND ACTIVE PLASMIN FOR THE TREATMENT OF THROMBOSIS
#9Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#10ACOUSTIC DRIVEN DRUG DELIVERY SYSTEMS
#11TARGETED POLYMERIZED NANOPARTICLES FOR CANCER TREATMENT
#12Trans-tympanic membrane delivery platform and uses thereof
#13SUSTAINED RELEASE OF ANTIINFECTIVES
#14Liposome loading
#15Stabilizing Camptothecin Pharmaceutical Compositions
#16Stabilizing camptothecin pharmaceutical compositions
#17MULTI-COMPONENT NANOCHAINS
#18Liposomes Useful for Drug Delivery
#19Liposome composition and method for producing same
#20Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#21Trans-tympanic membrane delivery platform and uses thereof
#22Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#23Stabilizing Camptothecin Pharmaceutical Compositions
#24Polymer-grafted nanobins
#25Combination HIV therapeutic
#26Stabilizing camptothecin pharmaceutical compositions
#27Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof
#28Targeted polymerized nanoparticles for cancer treatment
#29Liposome composition and method for producing same
#30Multi-component nanochains
#31Stabilizing Camptothecin Pharmaceutical Compositions
#32SUSTAINED RELEASE OF ANTIINFECTIVES
#33Mesoporous silica nanoparticles with a lipid bilayer coating for cargo delivery
#34SUSTAINED RELEASE OF ANTIINFECTIVES
#35Stabilizing Camptothecin Pharmaceutical Compositions
#36SUSTAINED RELEASE OF ANTIINFECTIVES
#37SUSTAINED RELEASE OF ANTIINFECTIVES
#38Compounds for targeting drug delivery and enhancing siRNA activity
#39Stabilizing camptothecin pharmaceutical compositions
#40Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
#41Multi-component nanoconstructs
#42Compositions and methods for treating HIV-associated neurocognitive disorders
#43Acoustic driven drug delivery systems
#44LIPOSOMES USEFUL FOR DRUG DELIVERY
#45Liposome loading
#46Lipid-based drug carriers for rapid penetration through mucus linings
#47Liposomes useful for drug delivery
#48Combination HIV therapeutic
#49Liposomal Irinotecan Preparations
#50Method and composition for treating rhinitis
#51Mesoporous silica nanoparticles with lipid bilayer coating for cargo delivery
#52Targeted liposomal delivery of cGMP analogues
#53Compositions and methods of tumor treatment utilizing nanoparticles
#54Methods and devices for preparation of lipid nanoparticles
#55Liposomes useful for drug delivery
#56Stabilizing Camptothecin Pharmaceutical Compositions
#57Nanotube trans-membrane channels mimicking biological porins
#58Pharmaceutical composition combining at least two distinct nanoparticles and a pharmaceutical compound, preparation and uses thereof
#59Multi-component nanochains
#60Tuneable delivery of nanoparticle bound active plasmin for the treatment of thrombosis
#61Liposome comprising elastin-like polypeptide and tumor cell targeting material and use thereof
#62Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#63Liposomes useful for drug delivery
#64Liposomes useful for drug delivery
#65Nanolipidic particle assembly populations
#66Method for producing liposome
#67Liposome composition and method for producing same
#68Liposome composition and method for producing same
#69Targeted polymerized nanoparticles for cancer treatment
#70Compounds for targeting drug delivery and enhancing siRNA activity
#71Compounds for targeting drug delivery and enhancing siRNA activity
#72Methods for the preparation of liposomes
#73Liposome loading
#74Immunosuppressive treatments, formulations and methods
#75Red blood cell membrane-derived microparticles and their use for the treatment of lung disease
#76Targeted nano-liposome co-entrapping anti-cancer drugs
#77Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
#78Multicompartmental lipid nanoparticles
#79Liposomes useful for drug delivery
#80Liposomes useful for drug delivery
#81Liposomes useful for drug delivery
#82Controlled drug release liposome composition
#83Hyaluronic acid-based drug delivery systems
#84Nanoparticle formulation
#85Magnetic-core polymer-shell nanocomposites with tunable magneto-optical and/or optical properties
#86Liposomes useful for drug delivery
#87Method for producing elastic vesicles
#88Coated lipid complexes and their use
#89Method and system for synthesizing nanocarrier based long acting drug delivery system for methadone
#90Method and system for synthesizing nanocarrier based long acting drug delivery system for dexamethasone
#91Method and system for synthesizing nanocarrier based long acting drug delivery system for buprenorphine
#92Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#93Method and system for synthesizing nanocarrier based long acting drug delivery system for insulin
#94Biocompatible particles and method for preparing same
#95Oligomer-contained nanoparticle complex release system
#96Methods and devices for preparation of lipid nanoparticles
#97Charge triggering of self-organized nanoparticles
#98Multi-component nanochains
#99Intraperitoneally-administered nanocarriers that release their therapeutic load based on the inflammatory environment of cancers
#100Method for making nanolipidic particles
#101Method for making nanolipidic particles
#102Nanolipidic particle assembly populations
#103Carrier-linked magnetic nanoparticle drug delivery composition and method of use
#104Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
#105LIPOSOME COMPRISING ELASTIN-LIKE POLYPEPTIDE AND TUMOR CELL TARGETING MATERIAL AND USE THEREOF
#106Method and composition for treating rhinitis
#107Dermatological compositions comprising avermectin nanocapsules
#108Compounds for targeting drug delivery and enhancing siRNA activity
#109Liposomal mitigation of drug-induced long QT syndrome and potassium delayed-rectifier current
#110Nanolipidic particles
#111Liposomes useful for drug delivery
#112Drug delivery nanocarriers targeted by landscape phage
#113SMALL INTERFERING RNA DELIVERY
#114Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#115Magnetic-core polymer-shell nanocomposites with tunable magneto-optical and/or optical properties
#116Direct cellular energy delivery system
#117Technique for drug and gene delivery to the cell cytosol
#118Lyophilized nanoemulsion
#119Method for making nanolipidic particles
#120Sustained Release of Antiinfectives
#121Lipid nanotube or nanowire sensor
#122Coated lipid complexes and their use
#123METHODS FOR ENCAPSULATING PLASMIDS IN LIPID BILAYERS
#124Nutritional supplement for the prevention of cardiovascular disease, alzheimer's disease, diabetes, and regulation and reduction of blood sugar and insulin resistance
#125Dermatological compositions comprising avermectin nanocapsules
#126Compositions comprising a lipid and copolymer of styrene and maleic acid
#127Serum-stable amphoteric liposomes
#128Cationic liposomes containing immune response generating moieties
#129Method for opening hollow structures made from magnetic nanoparticles
#130Increased effectiveness of allylamine drug compounds for topical treatment of fungal infections of the skin and skin appendages
#131Gas-containing liposomes
#132Antigen Delivery Compositions And Methods Of Use
#133Liposomal assembly for therapeutic and/or diagnostic use
#134Nanolipidic particles
#135Liposomes useful for drug delivery
#136Drug delivery nanocarriers targeted by landscape phage
#137Method and composition for treating rhinitis
#138Lipid nanotube or nanowire sensor
#139Direct cellular energy delivery system
#140Functionally reconstituted viral membranes containing adjuvant
#141Lipid bilayers on nano-templates
#142Non-invasive gene targeting to ocular cells
#143Cationic liposomes for gene transfer
#144Method of drug delivery to interstitial regions of the myocardium
#145Antigen delivery compositions and methods of use
#146Method and composition for treating rhinitis
#147Therapeutic supramolecules
#148Emulsion vehicle for poorly soluble drugs
#149Methods and compositions for inducing autoimmunity in the treatment of cancers
#150Methods for encapsulating plasmids in lipid bilayers
#151Method and system for systemic delivery of growth arresting, lipid-derived bioactive compounds
#152Cardiac disease treatment and device
#153ROS-responsive liposomes for specific targeting
#154Drug loaded flexible chitoplexes nanoparticles
#155ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages
#156ROS-responsive liposomes for specific targeting
#157ROS—responsive liposomes for specific targeting
#158ROS-responsive multilamellar liposomal vesicles for targeting inflammatory macrophages
#159Lipoleosomes as carriers for aromatic amide anesthetic compounds
#160Therapeutic liposome and method of treating a subject having cancer